Mesotherapy for local fat reduction

Summary Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French physician in the 1950s. Although popular in Europe for many medical purposes, it is used for local cosmetic fat reduction in the United S...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obesity reviews 2013-10, Vol.14 (10), p.780-791
Hauptverfasser: Jayasinghe, S., Guillot, T., Bissoon, L., Greenway, F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 791
container_issue 10
container_start_page 780
container_title Obesity reviews
container_volume 14
creator Jayasinghe, S.
Guillot, T.
Bissoon, L.
Greenway, F.
description Summary Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French physician in the 1950s. Although popular in Europe for many medical purposes, it is used for local cosmetic fat reduction in the United States. This paper reviews manuscripts indexed in PubMed/MEDLINE under ‘mesotherapy’, which pertains to local fat reduction. The history of lipolytic mesotherapy, the physiology of body fat distribution, the mechanism of action of different lipolytic stimulators and their increased efficacy in combination are reviewed. Mesotherapy falls into two categories. Lipolytic mesotherapy using lipolytic stimulators requires more frequent treatments as the fat cells are not destroyed and can refill over time. Ablative mesotherapy destroys fat cells with a detergent, causes inflammation and scarring from the fat necrosis, but requires fewer treatments. The historic and empiric mixing of sodium channel blocking local anaesthetics in mesotherapy solutions inhibits the intended lipolysis. Major mesotherapy safety concerns include injection site infections from poor sterile technique. Cosmetic mesotherapy directs the area from which fat is lost to improve self‐image. Studies were of relatively small number, many with limited sample sizes. Future research should be directed towards achieving a Food and Drug Administration indication rather than continuing expansion of off‐label use.
doi_str_mv 10.1111/obr.12049
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1432618207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3069238671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3919-3b31df74842266ac3a62e4854a01914d92975e012a486c524e603da3b3a099553</originalsourceid><addsrcrecordid>eNp1kEFPwjAYhhujEUUP_gGzhIseBv3arluPShRNUBKDyK0pWxeHg2K7Rfn3FgccTOzl6-F5n-_Li9AF4C741zMz2wWCmThAJ8B4HMaJmB7u_wm00Klzc4whFhSOUYvQBGPCxQnqPGlnqndt1Wod5MYGpUlVGeSqCqzO6rQqzPIMHeWqdPp8O9vo9f5u3H8Ih6PBY_9mGKZUgAjpjEKWxyxhhHCuUqo40SyJmMIggGWCiDjSGIhiCU8jwjTHNFM-prAQUUTb6Krxrqz5rLWr5KJwqS5LtdSmdhIYJRwSgmOPdv6gc1Pbpb9uQ0HE_QrsqeuGSq1xzupcrmyxUHYtActNc9I3J3-b8-zl1ljPFjrbk7uqPNBrgK-i1Ov_TXJ0-7JThk2icJX-3ieU_ZA8pnEk354HcjIeJhNgU8noD0hhgsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1431564860</pqid></control><display><type>article</type><title>Mesotherapy for local fat reduction</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Jayasinghe, S. ; Guillot, T. ; Bissoon, L. ; Greenway, F.</creator><creatorcontrib>Jayasinghe, S. ; Guillot, T. ; Bissoon, L. ; Greenway, F.</creatorcontrib><description>Summary Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French physician in the 1950s. Although popular in Europe for many medical purposes, it is used for local cosmetic fat reduction in the United States. This paper reviews manuscripts indexed in PubMed/MEDLINE under ‘mesotherapy’, which pertains to local fat reduction. The history of lipolytic mesotherapy, the physiology of body fat distribution, the mechanism of action of different lipolytic stimulators and their increased efficacy in combination are reviewed. Mesotherapy falls into two categories. Lipolytic mesotherapy using lipolytic stimulators requires more frequent treatments as the fat cells are not destroyed and can refill over time. Ablative mesotherapy destroys fat cells with a detergent, causes inflammation and scarring from the fat necrosis, but requires fewer treatments. The historic and empiric mixing of sodium channel blocking local anaesthetics in mesotherapy solutions inhibits the intended lipolysis. Major mesotherapy safety concerns include injection site infections from poor sterile technique. Cosmetic mesotherapy directs the area from which fat is lost to improve self‐image. Studies were of relatively small number, many with limited sample sizes. Future research should be directed towards achieving a Food and Drug Administration indication rather than continuing expansion of off‐label use.</description><identifier>ISSN: 1467-7881</identifier><identifier>EISSN: 1467-789X</identifier><identifier>DOI: 10.1111/obr.12049</identifier><identifier>PMID: 23800269</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adipocytes - metabolism ; Cosmetic ; Europe ; fat necrosis ; Humans ; Injections, Subcutaneous - adverse effects ; Injections, Subcutaneous - methods ; lipolysis ; Lipolysis - physiology ; Mesotherapy - adverse effects ; Mesotherapy - methods ; Obesity - therapy ; Subcutaneous Fat - metabolism ; United States</subject><ispartof>Obesity reviews, 2013-10, Vol.14 (10), p.780-791</ispartof><rights>2013 The Authors. reviews © 2013 International Association for the Study of Obesity</rights><rights>2013 The Authors. obesity reviews © 2013 International Association for the Study of Obesity.</rights><rights>Obesity Reviews © 2013 International Association for the Study of Obesity</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3919-3b31df74842266ac3a62e4854a01914d92975e012a486c524e603da3b3a099553</citedby><cites>FETCH-LOGICAL-c3919-3b31df74842266ac3a62e4854a01914d92975e012a486c524e603da3b3a099553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fobr.12049$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fobr.12049$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23800269$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jayasinghe, S.</creatorcontrib><creatorcontrib>Guillot, T.</creatorcontrib><creatorcontrib>Bissoon, L.</creatorcontrib><creatorcontrib>Greenway, F.</creatorcontrib><title>Mesotherapy for local fat reduction</title><title>Obesity reviews</title><addtitle>Obes Rev</addtitle><description>Summary Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French physician in the 1950s. Although popular in Europe for many medical purposes, it is used for local cosmetic fat reduction in the United States. This paper reviews manuscripts indexed in PubMed/MEDLINE under ‘mesotherapy’, which pertains to local fat reduction. The history of lipolytic mesotherapy, the physiology of body fat distribution, the mechanism of action of different lipolytic stimulators and their increased efficacy in combination are reviewed. Mesotherapy falls into two categories. Lipolytic mesotherapy using lipolytic stimulators requires more frequent treatments as the fat cells are not destroyed and can refill over time. Ablative mesotherapy destroys fat cells with a detergent, causes inflammation and scarring from the fat necrosis, but requires fewer treatments. The historic and empiric mixing of sodium channel blocking local anaesthetics in mesotherapy solutions inhibits the intended lipolysis. Major mesotherapy safety concerns include injection site infections from poor sterile technique. Cosmetic mesotherapy directs the area from which fat is lost to improve self‐image. Studies were of relatively small number, many with limited sample sizes. Future research should be directed towards achieving a Food and Drug Administration indication rather than continuing expansion of off‐label use.</description><subject>Adipocytes - metabolism</subject><subject>Cosmetic</subject><subject>Europe</subject><subject>fat necrosis</subject><subject>Humans</subject><subject>Injections, Subcutaneous - adverse effects</subject><subject>Injections, Subcutaneous - methods</subject><subject>lipolysis</subject><subject>Lipolysis - physiology</subject><subject>Mesotherapy - adverse effects</subject><subject>Mesotherapy - methods</subject><subject>Obesity - therapy</subject><subject>Subcutaneous Fat - metabolism</subject><subject>United States</subject><issn>1467-7881</issn><issn>1467-789X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFPwjAYhhujEUUP_gGzhIseBv3arluPShRNUBKDyK0pWxeHg2K7Rfn3FgccTOzl6-F5n-_Li9AF4C741zMz2wWCmThAJ8B4HMaJmB7u_wm00Klzc4whFhSOUYvQBGPCxQnqPGlnqndt1Wod5MYGpUlVGeSqCqzO6rQqzPIMHeWqdPp8O9vo9f5u3H8Ih6PBY_9mGKZUgAjpjEKWxyxhhHCuUqo40SyJmMIggGWCiDjSGIhiCU8jwjTHNFM-prAQUUTb6Krxrqz5rLWr5KJwqS5LtdSmdhIYJRwSgmOPdv6gc1Pbpb9uQ0HE_QrsqeuGSq1xzupcrmyxUHYtActNc9I3J3-b8-zl1ljPFjrbk7uqPNBrgK-i1Ov_TXJ0-7JThk2icJX-3ieU_ZA8pnEk354HcjIeJhNgU8noD0hhgsQ</recordid><startdate>201310</startdate><enddate>201310</enddate><creator>Jayasinghe, S.</creator><creator>Guillot, T.</creator><creator>Bissoon, L.</creator><creator>Greenway, F.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7TS</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201310</creationdate><title>Mesotherapy for local fat reduction</title><author>Jayasinghe, S. ; Guillot, T. ; Bissoon, L. ; Greenway, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3919-3b31df74842266ac3a62e4854a01914d92975e012a486c524e603da3b3a099553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adipocytes - metabolism</topic><topic>Cosmetic</topic><topic>Europe</topic><topic>fat necrosis</topic><topic>Humans</topic><topic>Injections, Subcutaneous - adverse effects</topic><topic>Injections, Subcutaneous - methods</topic><topic>lipolysis</topic><topic>Lipolysis - physiology</topic><topic>Mesotherapy - adverse effects</topic><topic>Mesotherapy - methods</topic><topic>Obesity - therapy</topic><topic>Subcutaneous Fat - metabolism</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jayasinghe, S.</creatorcontrib><creatorcontrib>Guillot, T.</creatorcontrib><creatorcontrib>Bissoon, L.</creatorcontrib><creatorcontrib>Greenway, F.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Physical Education Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Obesity reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jayasinghe, S.</au><au>Guillot, T.</au><au>Bissoon, L.</au><au>Greenway, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mesotherapy for local fat reduction</atitle><jtitle>Obesity reviews</jtitle><addtitle>Obes Rev</addtitle><date>2013-10</date><risdate>2013</risdate><volume>14</volume><issue>10</issue><spage>780</spage><epage>791</epage><pages>780-791</pages><issn>1467-7881</issn><eissn>1467-789X</eissn><abstract>Summary Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French physician in the 1950s. Although popular in Europe for many medical purposes, it is used for local cosmetic fat reduction in the United States. This paper reviews manuscripts indexed in PubMed/MEDLINE under ‘mesotherapy’, which pertains to local fat reduction. The history of lipolytic mesotherapy, the physiology of body fat distribution, the mechanism of action of different lipolytic stimulators and their increased efficacy in combination are reviewed. Mesotherapy falls into two categories. Lipolytic mesotherapy using lipolytic stimulators requires more frequent treatments as the fat cells are not destroyed and can refill over time. Ablative mesotherapy destroys fat cells with a detergent, causes inflammation and scarring from the fat necrosis, but requires fewer treatments. The historic and empiric mixing of sodium channel blocking local anaesthetics in mesotherapy solutions inhibits the intended lipolysis. Major mesotherapy safety concerns include injection site infections from poor sterile technique. Cosmetic mesotherapy directs the area from which fat is lost to improve self‐image. Studies were of relatively small number, many with limited sample sizes. Future research should be directed towards achieving a Food and Drug Administration indication rather than continuing expansion of off‐label use.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>23800269</pmid><doi>10.1111/obr.12049</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1467-7881
ispartof Obesity reviews, 2013-10, Vol.14 (10), p.780-791
issn 1467-7881
1467-789X
language eng
recordid cdi_proquest_miscellaneous_1432618207
source Wiley Online Library - AutoHoldings Journals; MEDLINE
subjects Adipocytes - metabolism
Cosmetic
Europe
fat necrosis
Humans
Injections, Subcutaneous - adverse effects
Injections, Subcutaneous - methods
lipolysis
Lipolysis - physiology
Mesotherapy - adverse effects
Mesotherapy - methods
Obesity - therapy
Subcutaneous Fat - metabolism
United States
title Mesotherapy for local fat reduction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T19%3A50%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mesotherapy%20for%20local%20fat%20reduction&rft.jtitle=Obesity%20reviews&rft.au=Jayasinghe,%20S.&rft.date=2013-10&rft.volume=14&rft.issue=10&rft.spage=780&rft.epage=791&rft.pages=780-791&rft.issn=1467-7881&rft.eissn=1467-789X&rft_id=info:doi/10.1111/obr.12049&rft_dat=%3Cproquest_cross%3E3069238671%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1431564860&rft_id=info:pmid/23800269&rfr_iscdi=true